Physician

Jon Luigi Haddad, M.D.

According to 2025 Medicare claims, Jon Haddad, M.D. (NPI: 1891762787) practices interventional cardiology in the Amarillo, TX market, with the plurality of this provider's patient population coming from Potter, TX. This provider's primary affiliated billing organization is NWTX PHYSICIAN NETWORK, PLLC (NPI: 1790109916; TIN: 300807116) and primary practice location at 79106-1741. Haddad is affiliated with the Texoma Clinical Partners ACO, LLC (ACO ID: A4585), Caravan Health ACO 43 LLC (ACO ID: A4974), Main Street Rural Health Magnolia ACO LLC (ACO ID: A5400), Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Haddad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,924 traditional Medicare patients, billed 8,129 HCPCS/CPT codes, and received $601,429 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 14,372 prescription claims across 1,237 beneficiaries totaling $1,893,932 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 15 claims. Open Payments data shows 54 records totaling $1,604. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $1,282,006 to $601,429. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $868,801 to $1,893,932. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $16,223 and ending at $28,108.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$898K$1.8M2015 Medicare payment: $1,282,006 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,328,213 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,461,470 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,392,666 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,591,229 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,795,413 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,616,747 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,268,064 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $677,946 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $601,429 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,92333,596$1,282,006
20163,00432,438$1,328,213
20172,70230,791$1,461,470
20182,71431,148$1,392,666
20192,99733,800$1,591,229
20202,70732,043$1,795,413
20212,39830,205$1,616,747
20222,42820,386$1,268,064
20232,02111,114$677,946
20241,9248,129$601,429

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$952K$1.9M2015 Drug cost: $868,801 (USD; Tot_Drug_Cst)2016 Drug cost: $947,068 (USD; Tot_Drug_Cst)2017 Drug cost: $953,779 (USD; Tot_Drug_Cst)2018 Drug cost: $970,057 (USD; Tot_Drug_Cst)2019 Drug cost: $1,392,109 (USD; Tot_Drug_Cst)2020 Drug cost: $1,679,208 (USD; Tot_Drug_Cst)2021 Drug cost: $1,834,838 (USD; Tot_Drug_Cst)2022 Drug cost: $1,897,946 (USD; Tot_Drug_Cst)2023 Drug cost: $1,904,293 (USD; Tot_Drug_Cst)2024 Drug cost: $1,893,932 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201576412,909$868,801
201677712,223$947,068
201778812,287$953,779
201886912,593$970,057
20191,17915,145$1,392,109
20201,18615,859$1,679,208
20211,18414,895$1,834,838
20221,17114,957$1,897,946
20231,23414,699$1,904,293
20241,23714,372$1,893,932

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$20K$39K2015 Medicare payment: $1,702 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $27,221 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $39,068 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $34,005 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R12$1,702
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R13$27,221
2019N/R18$39,068
2020N/RN/RN/R
2021N/R15$34,005
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more9092,125$90
78452Nuclear medicine studies of heart muscle at rest and with stress and spect422426$56
93306Ultrasound of heart with color-depicted blood flow, rate, direction and valve function844873$51
93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report8521,322$10
93010Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only484645$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban50826,426$504,339
EntrestoSacubitril/Valsartan40921,475$468,016
XareltoRivaroxaban20911,178$204,212
Repatha SureclickEvolocumab1635,790$110,001
VascepaIcosapent Ethyl1328,460$98,833

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.53$1,604Abbott Laboratories
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.1$600,002Vantis Vascular, Inc.

Explore More Providers

FAQ

What Medicare data is available for Jon Luigi Haddad, M.D.?

Tedicare shows public-source Medicare data for Jon Luigi Haddad, M.D. (NPI 1891762787), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jon Luigi Haddad, M.D. have ACO affiliation data?

Jon Luigi Haddad, M.D. is shown with ACO affiliation data for Texoma Clinical Partners ACO, LLC (MSSP, ACO ID A4585), Caravan Health ACO 43 LLC (MSSP, ACO ID A4974), Main Street Rural Health Magnolia ACO LLC (MSSP, ACO ID A5400), Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Jon Luigi Haddad, M.D.?

Jon Luigi Haddad, M.D. is linked to NWTX PHYSICIAN NETWORK, PLLC (billing NPI 1790109916) in the available physician profile data.

Does Jon Luigi Haddad, M.D. have Open Payments data?

Jon Luigi Haddad, M.D. has 54 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.